Antiproliferative properties of human alveolar macrophages

Respiration

Volumn 65, Issue 5, 1998, Pages 363-368

  Kessler, Romain ^a,b   Dumont, Serge ^a   Weitzenblum, Emmanuel ^a   Poindron, Philippe ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

Alveolar macrophages; Cytotoxicity; Gamma interferon; Lipopolysaccharide; Lung cancer

Indexed keywords

LIPOPOLYSACCHARIDE; RECOMBINANT GAMMA INTERFERON;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; LUNG INFECTION; LUNG LAVAGE; MALE; PRIORITY JOURNAL; SMOKING; SUPERNATANT;

BRONCHOALVEOLAR LAVAGE FLUID; HUMANS; INFECTION; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; LUNG DISEASES; LUNG NEOPLASMS; MACROPHAGE ACTIVATION; MACROPHAGES, ALVEOLAR; RECOMBINANT PROTEINS; SMOKING; TUMOR CELLS, CULTURED; U937 CELLS;

EID: 0031753585     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029296     Document Type: Article

References (28)

1. Lemarbre P, Hoidal J, Vesella R, Rinehart J: Human pulmonary macrophage tumor cell cytotoxicity. Blood 1980;55:612-617.
2. Kawatsu H, Hasegawa Y, Takagi E, Shimokata K: Human alveolar macrophages of anergic patients with lung cancer lack the responsiveness to recombinant interferon gamma. Chest 1991; 100:1277-1280.
3. Braun DP, Ahn MC, Harris JE, Chu E, Casey L, Wilbanks G, Siziopikou KP: Sensitivity of tumoricidal function in macrophages from different anatomical sites of cancer patients to modulation of arachidonic acid metabolism. Cancer Res 1993;53:3362-3368.
4. Keller R: Modulation of cell proliferation by macrophages: A possible function apart from cytotoxic tumour rejection. Br J Cancer 1974; 30:401-415.
5. Feinman R, Henriksen-De Stefano D, Tsujimoto M, Vilcek J: Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes. J Immunol 1987;138:635-640.
6. Tucker SD, Auzenne EJ, Sivaramakrishnan MR: Inhibition of tumor cell mitochondrial respiration by macrophage cytotoxic mediators distinct from interferon-γ. J Leukoc Biol 1993; 53:138-143.
7. Sung YJ, Dietert RR: Nitric oxide (NO)-in-duced mitochondrial injury among chicken NO-generating and target leucocytes. J Leukoc Biol 1994;56:52-58.
8. Okahara H, Yagita H, Miyake K, Okumura K: Involvement of very late antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor enhancement of experimental metastasis. Cancer Res 1994;54:3233-3236.
9. Vignaud M, Marie B, Klein N, Plénat F, Pech M, Borrelly J, Martinet N, Duprez A, Martinet Y: The role of platelet-derived growth factor production by tumor-associated macrophages in tumor stroma formation in lung cancer. Cancer Res 1994;54:5455-5463.
10. Smith DR, Kunkel SL, Burdick MD, Wilke CA, Orringer MB, Whyte RI, Strieter RM: Production of interleukin-10 by human bronchogenic carcinoma. Am J Pathol 1994;145:18-25.
11. Pankow W, Neumann K, Ruschoff J, Von Wiehert P: Human alveolar macrophages: Comparison of cell size, autofluorescence, and HLA-DR antigen expression in smokers and nonsmokers. Cancer Detect Prev 1995;19:268-273.
12. Schaberg T, Klein U, Rau M, Eller J, Lode H: Subpopulations of alveolar macrophages in smokers and nonsmokers: Relation to the expression of CD11/CD 18 molecules and superoxide anion production. Am J Respir Crit Care Med 1995;151:1551.
13. Weinberg JB, Chapman HA, Hibbs JB: Characterization of the effects of endotoxin on macrophage tumor cell killing. J Immunol 1978; 121:72-80.
14. Drath DB: Modulation of pulmonary macrophage Superoxide release and tumouricidal activity following activation by biological response modifiers. Immunopharmacology 1986;12:117-126.
15. Thomassen MJ, Ahmad M, Barna BP, Antal J, Wiedemann HP, Meeker DP, Klein J, Bauer L, Gibson V, Andresen S, Bukowski RM: Induction of cytokine messenger RNA and secretion in alveolar macrophages and blood monocytes from patients with lung cancer receiving granulocyte-macrophage colony-stimulating factor therapy. Cancer Res 1991;51:857-862.
16. Nii A, Utsugi T, Fan D, Denkins Y, Pak C, Brown D, Van Hoogevest P, Fidler IJ: Optimization of the liposomes encapsulating a new lipopeptide CGP 31362 for efficient activation of tumoricidal properties in monocytes and macrophages. J Immunother 1991;10:236-246.
17. Faradji A, Bohbot A, Schmitt-Goguel M, Roeslin N, Dumont S, Wiesel ML, Lallot C, Eber M, Bartholeyns J, Poindron P: Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with non-small-cell lung cancer: Toxicity and immunomodulatory effects. Cancer Immunol Immunother 1991;33:319-326.
18. Halme M, Maasilta P, Repo H, Ristola M, Taskinen F, Mattson K, Cantell K: Inhaled recombinant Interferon gamma in patients with lung cancer: Pharmacokinetics and effects on chemiluminescence responses of alveolar macrophages and peripheral blood neutrophils and monocytes. Int J Radiat Oncol Biol Phys 1995; 31:93-101.
19. Yamaguchi E, Itoh A, Furuya K, Miyamoto H, Abe S, Kawakami Y: Release of tumor necrosis factor-α from human alveolar macrophages is decreased in smokers. Chest 1993;103:479-483.
20. Dumont S, Mabondzo A, Hartmann D, Gilgenv krantz JL, Kessler R, Poindron P, Bartholeyns J: Study of the dependence of human monov cytes and macrophages antitumoral properties upon TNF-α expression or release. Anticancer Res 1990;10:949-954.
21. Audran R, Dazord L, Toujas L: Interactions between human macrophages and tumor cells in three-dimensional cultures. Cancer Immunol Immunother 1994;39:299-304.
22. Munn DH, Cheung NK: Antibody-independent phagocytosis of tumor cells by human monocyte-derived macrophages cultured in recombinant macrophage colony-stimulating factor. Cancer Immunol Immunother 1995;41: 46-52.
23. Lohmann-Matthes ML, Steinmüller C, Franke-Ullmann G: Pulmonary macrophages. Eur Respir J 1994;7:1678-1689.
24. Van de Loosdrecht AA, Ossenkoppele GJ, Beelen RH, Broekhoven MG, Drager AM, Langenhuijsen MM: Apoptosis in tumor necrosis factor-alpha-dependent. monocyte-mediated leukemic cell death: A functional, morphologic, and flow cytometric analysis. Exp Hematol 1993;21:1628-1639.
25. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Rucco L: The origin and function of tumor-associated macrophages. Immunol Today 1992;13:265-270.
26. Killion JJ, Fidler IJ: Systemic targeting of liposome-encapsulated immunomodulators to macrophages for treatment of cancer metastasis. Immunomethods 1994;4:273-279.
27. Eisenberg BL, Taylor DD, Weese JL: Aerosolized gamma interferon and lipopolysaccharide enhance cytotoxicity of murine pulmonary alveolar macrophages. J Immunother 1991;10: 51-56.
28. Kessler R, Dumont S, Bartholeyns J, Weitzenblum E, Poindron P: Antitumoral potential of aerosolized interferon-γ in mice bearing lung metastases. Am J Respir Cell Mol Biol 1994; 10:202-206.